1. Home
  2. ZYXI vs FMY Comparison

ZYXI vs FMY Comparison

Compare ZYXI & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • FMY
  • Stock Information
  • Founded
  • ZYXI 1996
  • FMY 2005
  • Country
  • ZYXI United States
  • FMY United States
  • Employees
  • ZYXI N/A
  • FMY N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FMY Finance/Investors Services
  • Sector
  • ZYXI Health Care
  • FMY Finance
  • Exchange
  • ZYXI Nasdaq
  • FMY Nasdaq
  • Market Cap
  • ZYXI 44.8M
  • FMY 50.5M
  • IPO Year
  • ZYXI N/A
  • FMY N/A
  • Fundamental
  • Price
  • ZYXI $1.50
  • FMY $12.25
  • Analyst Decision
  • ZYXI Hold
  • FMY
  • Analyst Count
  • ZYXI 3
  • FMY 0
  • Target Price
  • ZYXI $3.00
  • FMY N/A
  • AVG Volume (30 Days)
  • ZYXI 103.1K
  • FMY 10.1K
  • Earning Date
  • ZYXI 10-23-2025
  • FMY 01-01-0001
  • Dividend Yield
  • ZYXI N/A
  • FMY 6.98%
  • EPS Growth
  • ZYXI N/A
  • FMY N/A
  • EPS
  • ZYXI N/A
  • FMY N/A
  • Revenue
  • ZYXI $144,808,000.00
  • FMY N/A
  • Revenue This Year
  • ZYXI N/A
  • FMY N/A
  • Revenue Next Year
  • ZYXI $7.07
  • FMY N/A
  • P/E Ratio
  • ZYXI N/A
  • FMY N/A
  • Revenue Growth
  • ZYXI N/A
  • FMY N/A
  • 52 Week Low
  • ZYXI $1.23
  • FMY $10.71
  • 52 Week High
  • ZYXI $9.42
  • FMY $12.17
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 42.77
  • FMY 48.65
  • Support Level
  • ZYXI $1.44
  • FMY $12.26
  • Resistance Level
  • ZYXI $1.55
  • FMY $12.37
  • Average True Range (ATR)
  • ZYXI 0.09
  • FMY 0.08
  • MACD
  • ZYXI 0.02
  • FMY -0.00
  • Stochastic Oscillator
  • ZYXI 29.03
  • FMY 39.13

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

Share on Social Networks: